A gynecological device is a medical device that is used to
promote female health or to protect and preserve reproductive health for
females. This is a very broad category and includes products such as watches,
calculators, bandages, and hygienic towels. While many of these products have
been clinically tested and found to be safe for female health, there are still
a few devices in the market that pose threats to female reproductive health.
Gynecological devices are usually fall into three categories: medical devices, biological
safety devices, and mechanical devices. Medical devices are those that prevent
the risk of injury or trauma to a woman's reproductive organs from medical
interventions. Biologic safety devices are those that protect a female's health
by promoting female reproductive health. Finally, mechanical devices are those
that help maintain a woman's reproductive health and allow her to achieve or
reach their desired fertility or pregnancy. The use of any of these
unsupervised or unsafe medical procedures poses a risk to a woman's
reproductive health and should be avoided at all costs.
Market
Dynamics
The main factors driving the growth of gynecological
devices market are the rapid increase of gynecological diseases such as
uterine fibroids, endometriosis, and vaginitis and the introduction of new
innovative gynecological devices in the market. For instance, according to the
U.S. National Center for Biotechnology Information, approximately 97 per 1000
women suffer from gynecological diseases in the U.S., among which approximately
53 per 1000 women suffer from menstrual disorders. Rising awareness about
gynecological health and preventive check-up to avoid sexually transmitted
diseases (STD) is expected to boost the market growth. Moreover soaring numbers
of surgical procedures such as female sterilization, endoscopy, laparoscopy,
and ablation are driving the demand for gynecological devices.
However strict regulatory orders by governmental bodies
across the globe related to the safety of gynecological devices and products
are the main restraining factor hindering the growth of the market. Moreover,
the rapid increase of alternative therapies such as improved drug therapy and
personalized medicines are also expected to hinder the market growth.
This market is distributed in five regions that include
North America, Europe, Asia-Pacific, Middle East, and Africa, and Latin
America. Among these, North America is estimated to hold a bigger share of the
gynecological devices market owing to the high rate of awareness related to the
availability of diagnostic treatments and tests, increasing reimbursement full
coverage, and well equipped medical infrastructure. For instance, according to
the Centers for Medicare & Medicaid Services in 2019, there were approximately
43,000 full-time and board-certified OB-GYN practitioners in the U.S. The
market in the Asia Pacific is estimated to witness significant growth in the
market owing to the presence of key players in the region and governments'
initiative to control the rapid expansion of the population.
Competitive Analysis
Key players operating in the gynecological devices market
include Olympus Corporation, Medtronic, Richard Wolf GmbH, Boston Scientific
Corporation, Karl Storz GmbH& Co. KG, Cooper Surgical, Inc., Stryker
Corporation, MedGyn Product Inc., Hologic, Inc., and Ethicon, Inc.
In 2018, Lina Medical launched the OperaScope, which can be used to diagnose and treat hysteroscopy. In 2020 Creek Women's Health and Lupin Pharmaceuticals Inc. agreed to add Nella women’s health product to Lupin's portfolio.
No comments:
Post a Comment